OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

REPL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Replimune Group (REPL) Earnings Date & Reports

Replimune Group Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

REPL is expected to report earnings to fall 76.00% to -73 cents per share on July 31

Replimune Group REPL Stock Earnings Reports

Q2'25

Est.

$-0.74

Q1'25

Missed

by $2.35

Q4'24

Missed

by $0.03

Q3'24

Beat

by $0.14

Q2'24

Beat

by $0.08

The last earnings report on May 22 showed earnings per share of -306 cents, missing the estimate of -72 cents. With 798.75K shares outstanding, the current market capitalization sits at 751.60M.

View a ticker or compare two or three

Compare

REPL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For REPL
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for REPL (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

500 Unicorn Park Drive

Phone

+1 781 222-9600

Employees

284

Web

https://www.replimune.com